GenMark Diagnostics (GNMK) Reports In-Line Q1 EPS, Maintains FY Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
GenMark Diagnostics Reports Q1 Financial Results
May 5, 2015 4:07 PM EDTFirst Quarter Revenue of $10.1 Million, Up 28% Versus Prior Year
XT-8 Installed Base Expanded by 22 to 562
European ePlex Launch on Track for Fourth Quarter 2015
Full Year Revenue Guidance Maintained at $38-40 Million
CARLSBAD, Calif.--(BUSINESS WIRE)-- GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today reported first quarter 2015 financial results.
As previously reported, revenue for the first quarter of 2015 was $10.1 million, an increase of... More
